|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-12-26
|
|
pubmed:abstractText |
Hypercholesterolemia (HCHL) and hypertriglyceridemia (HTRG) have emerged as the most significant metabolic consequences of therapy with sirolimus. Lipid status can be exacerbated by a variety of factors in the posttransplant setting, including genetic factors. Apoliprotein E (Apo E) polymorphism is an established genetic risk factor for hyperlipidemia. We studied the association between Apo E gene polymorphisms and lipids after kidney transplantation in patients undergoing sirolimus treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1705-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16378065-Adult,
pubmed-meshheading:16378065-Aged,
pubmed-meshheading:16378065-Apolipoproteins E,
pubmed-meshheading:16378065-Cholesterol,
pubmed-meshheading:16378065-Creatinine,
pubmed-meshheading:16378065-Female,
pubmed-meshheading:16378065-Gene Frequency,
pubmed-meshheading:16378065-Genotype,
pubmed-meshheading:16378065-Humans,
pubmed-meshheading:16378065-Hyperlipidemias,
pubmed-meshheading:16378065-Immunosuppressive Agents,
pubmed-meshheading:16378065-Kidney Transplantation,
pubmed-meshheading:16378065-Lipoproteins, LDL,
pubmed-meshheading:16378065-Male,
pubmed-meshheading:16378065-Middle Aged,
pubmed-meshheading:16378065-Retrospective Studies,
pubmed-meshheading:16378065-Risk Factors,
pubmed-meshheading:16378065-Sirolimus,
pubmed-meshheading:16378065-Triglycerides,
pubmed-meshheading:16378065-Virginia
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Apolipoprotein E genotypes as predictors of high-risk groups for developing hyperlipidemia in kidney transplant recipients undergoing sirolimus treatment.
|
|
pubmed:affiliation |
Division of Transplantation, Department of Surgery, Virginia Commonwealth University, Richmond, VA 23298-0248, USA. dgmaluf@vcu.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
